Work

TAKE Steps: a pilot randomized controlled trial of an adolescent sexually transmitted infection (STI) and HIV prevention intervention

Year: 2026
Type: article
Abstract: Our primary aim was to assess the Treat Act Know Engage (TAKE) Steps intervention’s effect on sexually transmitted infection (STI) and HIV prevention self-efficacy, a hypothesized mediator of intervention effect. Secondarily, we aimed to measure HIV prevention behavior outcomes and intervention feasibility and acceptability. This pilot randomized controlled trial enrolled 13–19 year-olds with STIs at Philadelphia-area pediatric clinics, 2022–2024. Participants were randomized to TAKE Steps, a four-session motivational interviewing, communication skill-building and navigation intervention or enhanced usual care (EUC; quarterly text message-based STI/HIV testing reminders.) Mixed effects linear regression compared between-arm self-efficacy score changes from baseline to three months (primary outcome). We measured feasibility as proportions of eligible patients enrolled and intervention participants retained. One-week and three-month surveys measured acceptability. Chi-squared testing compared prevention behavior between arms. Forty-two intervention and 40 EUC participants were 96% Black and 90% female. Regarding our primary endpoint, there were no significant between-group self-efficacy differences over time (+ 1.67, − 0.89, 4.23). Recruitment feasibility was 15% and we retained 67% of intervention participants. Acceptability was 96%. At six months, more intervention than EUC participants completed STI retesting (80% vs 58%, p = 0.03) and HIV testing (63% vs 45%, p = 0.11). Three intervention and no EUC participants initiated HIV pre-exposure prophylaxis by three months (p = 0.11). TAKE Steps is a promising and highly acceptable STI and HIV prevention intervention. Participation led to increased intervention group, but not between-group self-efficacy and uptake of STI and HIV testing. Future research should optimize recruitment and retention and examine behavioral mediators. ClinicalTrials.gov. NCT05215262.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W7237333371
FWCI:
Cites:
Cited by:
Related to: